Loading…
The development and optimisation of nanobody based electrochemical immunosensors for IgG
•Nanobodies have been used on impedimetric immunosensors to detect rabbit IgG.•Unmodified nanobody sensors displayed a decrease in resistance upon analyte recognition.•Nanobodies were modified with a peptide spacer, effectively reversing this phenomena.•The use of a spacer also increased the sensiti...
Saved in:
Published in: | Sensors and actuators. B, Chemical Chemical, 2016-10, Vol.234, p.478-484 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Nanobodies have been used on impedimetric immunosensors to detect rabbit IgG.•Unmodified nanobody sensors displayed a decrease in resistance upon analyte recognition.•Nanobodies were modified with a peptide spacer, effectively reversing this phenomena.•The use of a spacer also increased the sensitivity of the immunosensor.
Biosensors are increasingly heralded for their potential to create inexpensive diagnostic devices which are sensitive, selective and easy to use. One of the key categories of biosensor are immunosensors, which have historically used antibodies as bioreceptors. Though widely used, antibodies bring inherent limitations such as variability, limited stability and their reliance on animal sources.
This has led to the development of alternative immuno-reagents such as non-antibody binding proteins (NABPs). These are low molecular weight proteins which largely avoid the aforementioned advantages of antibodies. They are commonly produced by bacteria enabling the use of DNA technology to manipulate bioreceptors at the molecular level.
Single chain VHHs (commonly known as nanobodies) are an antibody derived NABP adapted from camelid heavy chain antibodies which are the isolated binding domain. Whilst nanobodies have been used for diagnostic and therapeutic applications, they have limited demonstration in biosensors.
In this study, both antibodies and nanobodies were used to construct a biosensor. In addition nanobody performance was optimised by introducing a novel peptide spacer. The role of nanobody orientation and spacing was thus investigated and spacer length was optimised, leading to an increase in the sensitivity of the biosensor. |
---|---|
ISSN: | 0925-4005 1873-3077 |
DOI: | 10.1016/j.snb.2016.04.132 |